A detailed history of Geller Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Geller Advisors LLC holds 3,546 shares of EW stock, worth $265,276. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,546
Previous 3,313 7.03%
Holding current value
$265,276
Previous $306,000 23.53%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$59.7 - $93.78 $13,910 - $21,850
233 Added 7.03%
3,546 $234,000
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $10,116 - $11,317
120 Added 3.76%
3,313 $306,000
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $2,974 - $3,917
-41 Reduced 1.27%
3,193 $305,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $21,166 - $26,671
343 Added 11.86%
3,234 $246,000
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $190,935 - $257,355
-2,756 Reduced 48.8%
2,891 $200,000
Q2 2023

Aug 09, 2023

BUY
$81.41 - $94.33 $257,418 - $298,271
3,162 Added 127.24%
5,647 $532,000
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $184,536 - $210,007
2,485 New
2,485 $205,000
Q2 2022

Aug 10, 2022

SELL
$86.5 - $128.27 $169,972 - $252,050
-1,965 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $12,235 - $15,400
120 Added 6.5%
1,965 $231,000
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $212 - $261
2 Added 0.11%
1,845 $239,000
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $12,452 - $14,852
-121 Reduced 6.16%
1,843 $209,000
Q2 2021

Aug 09, 2021

BUY
$83.84 - $104.76 $164,661 - $205,748
1,964 New
1,964 $203,000
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $75,285 - $86,194
-1,050 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$61.55 - $75.43 $64,627 - $79,201
1,050 New
1,050 $231,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Geller Advisors LLC Portfolio

Follow Geller Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geller Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geller Advisors LLC with notifications on news.